Charles River Laboratories International's quarterly Total Liabilities
declined
from Sep. 2025 (€3,461.67 Mil) to Dec. 2025 (€3,351.29 Mil) but then
increased
from Dec. 2025 (€3,351.29 Mil) to Mar. 2026 (€4,101.83 Mil).
Charles River Laboratories International's annual Total Liabilities
declined
from Dec. 2023 (€4,159.52 Mil) to Dec. 2024 (€3,839.36 Mil) and
declined
from Dec. 2024 (€3,839.36 Mil) to Dec. 2025 (€3,351.29 Mil).
Charles River Laboratories International Total Liabilities Related Terms
Charles River Laboratories International Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Total Liabilities Chart
Charles River Laboratories International Annual Data
Charles River Laboratories International Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a Total Liabilities of €4,102 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Total Liabilities too high?
Charles River Laboratories International's current Total Liabilities is €4,102 Mil. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Total Liabilities compare to RVTY and QGEN?
Charles River Laboratories International's Total Liabilities of €4,102 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Charles River Laboratories International and its competitors. Charles River Laboratories International's current Total Liabilities is €4,102 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Total Liabilities of €4,102 Mil. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Total Liabilities is €4,102 Mil. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Total Liabilities is €4,102 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.
Key valuation signals for MIL:1CRL:
Total Liabilities: €4,102 Mil
GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score
Get the complete analysis for MIL:1CRL
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
